Seres Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Seres Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates

Seres Therapeutics (MCRB) Misses Q2 EPS by 16c

August 3, 2021 7:43 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q2 EPS of ($0.53), $0.16 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $5.26 million versus the consensus estimate of $5.34 million.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More